Cleerly vs Milvue

Cleerly fits a cardiac CT service. It takes coronary CTA studies, measures plaque volume and composition, and its home page names PowerScribe for reporting. Cleerly's press page lists UnitedHealthcare, Cigna, Humana and Aetna among payers covering its plaque analysis, and Aetna requires an FDA-cleared platform. Its inputs are CCTA studies and Milvue's are CR and DX radiographs, so a cardiac CT program and an emergency X-ray queue make separate purchases.

Milvue reads conventional radiographs. It flags fractures, dislocations and joint effusions, moves flagged exams up the worklist, and carries CE class IIa under MDR plus two FDA clearances, SmartChest (K232410, May 2024) and TechCare Trauma (K242171, January 2025). Its partner page lists Dedalus and Osimis among the RIS and PACS vendors. A hospital radiology department with an emergency X-ray queue buys it. The vendor says TechCare Trauma reached a fracture AUC of 0.962 in its FDA study (K242171), with a 22% gain in adult fracture sensitivity.